Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Mint-Data for Personalized Medicine at Cancer Center in Tübingen/Germany

Compiling structured real-world-data from different medical disciplines, such as molecular genetics, laboratory medicine, pathology or radiology, to generate insights for specific diseases represents the “holy grail” of Personalized Medicine.

The Cancer Center in Tübingen/Germany initiated the project “Structured data in Oncology” focusing on this target. Just like all other disciplines, the radiology team led by Prof. Konstantin Nikolaou is asked to provide structured radiological information from clinical routine to be included into the data pool.

The currently prevalent dictated prose report does not meet that requirement since the information is not structured and cannot be forwarded in a machine-readable way.

In cooperation with Mint Medical new reading profiles for selected use cases were defined and configured in mint Lesion. This was done in such a way that all relevant information is captured and the efficiency in the reading process is ensured. The number of applied use cases in mint Lesion will further increase within the next months.

Related Resources

Related Resources

The Mint Experience of Dr. Stephen Raskin, Sheba Medical Center in Tel Aviv

From my initial experience with mint Lesion™ software, and over the time I have been using it, I have been pleased with the software and come to…

How mint Lesion 3.5 helps you to benefit from Artificial Intelligence in Radiology

According to researchers, every adult makes 35,000 decisions each day. While there are no numbers in literature about how many decisions a radiologist…

AI-powered quantification of bone metastasis in prostate cancer

Prostate cancer is the second most common cancer among men, and there are now effective treatments for the disease. New therapies available on the…